SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-059242
Filing Date
2023-07-24
Accepted
2023-07-24 16:32:41
Documents
13
Period of Report
2023-07-24
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea182199-8k_enzobiochem.htm   iXBRL 8-K 29528
2 PRESS RELEASE, DATED JULY 24, 2023, ISSUED BY ENZO BIOCHEM, INC. ea182199ex99-1_enzobio.htm EX-99.1 7476
  Complete submission text file 0001213900-23-059242.txt   211585

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE enz-20230724.xsd EX-101.SCH 2944
4 XBRL LABEL FILE enz-20230724_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE enz-20230724_pre.xml EX-101.PRE 22350
7 EXTRACTED XBRL INSTANCE DOCUMENT ea182199-8k_enzobiochem_htm.xml XML 3477
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-09974 | Film No.: 231105403
SIC: 8071 Services-Medical Laboratories